Leadership in Innovation | Gerald Chan | Voices in Leadership
Gerald Chan, Chairman and CEO of Morningside Group, spoke at the Harvard T.H. Chan School of Public Health as part of the Voices in Leadership series on September 9, 2015.
Watch the entire “Voices in Leadership” series at www.hsph.me/voices.
The Voices in Leadership webcast discussion series at Harvard T. H Chan School of Public Health invites leaders to speak about their experiences making decisions that affect global health. Highly interactive and candid, the series is produced in The Leadership Studio for a student audience. The high-definition webcast is streamed live and posted for future viewing. Students learn from experienced leaders about decisions that were effective, decisions that failed, and which decisions, if any, could have been made differently. Watch the entire series at www.hsph.me/voices.
Gerald Chan is the co-founder of Morningside, a private investment group with venture, private equity and property investments. In the life science sector, Morningside focuses on start-up biotechnology companies founded on novel scientific discoveries. Gerald serves on the boards of Advanced Cell Diagnostics, Stealth BioTherapeutics, Synchroneuron, Apellis, Atea, Kezar, Nucana, Aduro, VTI and Matrivax. Gerald is a member of the Global Advisory Council of the International Society for Stem Cell Research, the Dean’s Board of Advisors of the Harvard T.H. Chan School of Public Health and the advisory boards of the Cold Spring Harbor Conferences Asia, the Johns Hopkins Nanjing Center and the Columbia University Center for Radiological Research. He is a trustee of Fudan University in Shanghai and chairs the Board of Overseers of Morningside College of the Chinese University of Hong Kong. He is a member of the Council on Foreign Relations, New York.
Gerald received his BS and MS degrees in engineering from UCLA, his Master’s degree in medical radiological physics and Doctor of Science degree in radiation biology from Harvard University. He did his post-doctoral training at the Dana-Farber Cancer Institute as a fellow of the Leukemia Society of America. The Chinese University of Hong Kong and the University of Glasgow in Scotland have conferred on him honorary degrees. He was elected to an honorary fellowship at Wolfson College of Oxford University.
Видео Leadership in Innovation | Gerald Chan | Voices in Leadership канала Harvard University
Watch the entire “Voices in Leadership” series at www.hsph.me/voices.
The Voices in Leadership webcast discussion series at Harvard T. H Chan School of Public Health invites leaders to speak about their experiences making decisions that affect global health. Highly interactive and candid, the series is produced in The Leadership Studio for a student audience. The high-definition webcast is streamed live and posted for future viewing. Students learn from experienced leaders about decisions that were effective, decisions that failed, and which decisions, if any, could have been made differently. Watch the entire series at www.hsph.me/voices.
Gerald Chan is the co-founder of Morningside, a private investment group with venture, private equity and property investments. In the life science sector, Morningside focuses on start-up biotechnology companies founded on novel scientific discoveries. Gerald serves on the boards of Advanced Cell Diagnostics, Stealth BioTherapeutics, Synchroneuron, Apellis, Atea, Kezar, Nucana, Aduro, VTI and Matrivax. Gerald is a member of the Global Advisory Council of the International Society for Stem Cell Research, the Dean’s Board of Advisors of the Harvard T.H. Chan School of Public Health and the advisory boards of the Cold Spring Harbor Conferences Asia, the Johns Hopkins Nanjing Center and the Columbia University Center for Radiological Research. He is a trustee of Fudan University in Shanghai and chairs the Board of Overseers of Morningside College of the Chinese University of Hong Kong. He is a member of the Council on Foreign Relations, New York.
Gerald received his BS and MS degrees in engineering from UCLA, his Master’s degree in medical radiological physics and Doctor of Science degree in radiation biology from Harvard University. He did his post-doctoral training at the Dana-Farber Cancer Institute as a fellow of the Leukemia Society of America. The Chinese University of Hong Kong and the University of Glasgow in Scotland have conferred on him honorary degrees. He was elected to an honorary fellowship at Wolfson College of Oxford University.
Видео Leadership in Innovation | Gerald Chan | Voices in Leadership канала Harvard University
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Decision Making for Health Professionals | Harvey Fineberg, President of the Institute of MedicineDo We Get What We Pay For in American Healthcare?Ronnie Chan, Hong Kong Entrepreneur: Zillow Speaker SeriesPriority Setting in Global HealthAmbassador J. Stapleton Roy: “The Changing Geopolitics of East Asia: Reflections of an Ambassador"Davos 2015 - Global Health SecurityPublic Health Leadership in Challenging Times: Learning from the Past and Preparing for the FutureThe Four Behaviors Of Innovative Leaders | ForbesKai Fu Lee | Cambridge UnionLeading the Life You Want | Stew Friedman | Talks at GoogleFireside Chat with World-Renowned AI Expert, Kai-Fu Lee at the Hong Kong FinTech WeekMake the Impossible Possible: Bill StricklandWhat's Special About NYU Steinhardt?Hacking Humanity | Andrew Lo | TEDxCambridgeSalonKai-Fu Lee: AI SuperpowersChanging Healthcare through IT Innovation - Harvard School of Public HealthA Transformational Gift to the Harvard School of Public HealthThe Trouble with US HealthcareKevin Rudd ─ Understanding China under Xi JinpingGraduate Studies in Educational Leadership